iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. LULU
2. ZS
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium
(NASDAQ: DTIL) Delayed: 7.47 +0.10 (1.36%)
Previous Close $7.37    52 Week High $ 
Open $7.32    52 Week Low $ 
Day High $7.58    P/E N/A 
Day Low $7.32    EPS $ 
Volume 124,285